会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明公开
    • Method for the expression of a recombinant protein in a mammalian cell
    • Verfahren zur表达在einerSäugetierzelle中重组重组蛋白
    • EP2314707A1
    • 2011-04-27
    • EP09174068.8
    • 2009-10-26
    • Amarna Therapeutics B.V.
    • De Vries, Walter Gerhardus
    • C12N15/85C12N5/10
    • C12N15/85C12N2710/22022C12N2800/108
    • The invention relates to methods for the production of a recombinant protein in a mammalian cell and methods to enhance the production of recombinant proteins in mammalian cells. More in particular, the invention provides a cell for the production of a recombinant protein of interest wherein said cell is permissive to a polyomavirus and wherein said cell comprises the genetic elements A and B wherein A encodes a polyomaviral large T antigen or a functional equivalent thereof and B comprises a gene encoding a protein of interest under the functional control of a polyomaviral origin of replication or a functional equivalent thereof, wherein said cell lacks the capability to express a polyomaviral small T antigen or a functional equivalent thereof as well as the capability to express a polyomavirus capsid protein.
    • 本发明涉及用于在哺乳动物细胞中产生重组蛋白的方法以及增强哺乳动物细胞中重组蛋白产生的方法。 更具体地,本发明提供了用于产生感兴趣的重组蛋白质的细胞,其中所述细胞允许多瘤病毒,并且其中所述细胞包含遗传元件A和B,其中A编码多分子量大的抗原或其功能等同物 和B包含编码目的蛋白质的基因在复合多功能病毒复制起点或其功能等同物的功能控制下,其中所述细胞缺乏表达多细胞病毒小T抗原或其功能等同物的能力,以及 表达多瘤病毒衣壳蛋白。
    • 2. 发明公开
    • Method for the production of recombinant polymavirus vector particles
    • Verfahren zur Herstellung von rekombinanten Polymavirus-Vektorenteilchen
    • EP2243836A1
    • 2010-10-27
    • EP09158498.7
    • 2009-04-22
    • Amarna Therapeutics B.V.
    • Vries, De, Walter Gerhardus
    • C12N15/86
    • C12N7/00C12N2710/22051C12N2710/22052
    • The present invention relates to improved methods for the production of viral particles, viral vectors and recombinant proteins. In particular, the invention relates to improved methods for the production of recombinant polyomavirus vector particles and polyoma vector production cell lines. More in particular, the invention relates to methods for the production of simian polyoma viral vector particles such as simian virus 40 (SV40) viral vector particles. The invention also relates to compositions comprising viral vectors and uses thereof and viral vector particles to treat genetic disorders, transplant rejection, autoimmune diseases, infectious diseases, allergies or cancer. The invention also relates to methods for the production of recombinant proteins in mammalian cells and methods to enhance the production of recombinant proteins in mammalian cells.
    • 本发明涉及用于生产病毒颗粒,病毒载体和重组蛋白质的改进方法。 特别地,本发明涉及用于生产重组多瘤病毒载体颗粒和多瘤病毒载体生产细胞系的改进方法。 更具体地,本发明涉及用于生产猿猴多病毒病毒载体颗粒如猿猴病毒40(SV40)病毒载体颗粒的方法。 本发明还涉及包含病毒载体及其用途的组合物和用于治疗遗传疾病,移植排斥,自身免疫疾病,感染性疾病,过敏或癌症的病毒载体颗粒。 本发明还涉及用于在哺乳动物细胞中产生重组蛋白的方法以及增强哺乳动物细胞中重组蛋白产生的方法。